MiR-146a-5p correlates with clinical efficacy in patients with psoriasis treated with the tumour necrosis factor-alpha inhibitor adalimumab

E. Mensà, R. Recchioni, F. Marcheselli, K. Giuliodori, V. Consales, E. Molinelli, F. Prattichizzo, M. R. Rippo, A. Campanati, A. D. Procopio, F. Olivieri, A. M. Offidani

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)787-789
Number of pages3
JournalBritish Journal of Dermatology
Volume179
Issue number3
DOIs
Publication statusPublished - Sep 1 2018

ASJC Scopus subject areas

  • Dermatology

Cite this